异形性肺纤维化:我们站在哪里,还有多远的路要走?
Vaishali Singh1,2, Ilya Ulasov3,4, Sachin Gupta2
1Endocrine Research Lab, Department of Zoology, Kutir Post Graduate College, Jaunpur-222146, U.P., India.
异形性肺纤维化 (IPF) 是一种进展性肺病,原因不明. 新的药物如皮尔芬尼和宁泰达尼布减缓疾病的进展,为IPF患者提供希望.
科学领域:
- 肺部医学 肺部医学
- 纤维化肺部疾病 纤维化肺部疾病
- 医学研究 医学研究
背景情况:
- 异形性肺纤维化 (IPF) 是一种严重的,进展性肺病,死亡率高.
- 它的确切原因仍然未知,尽管进行了广泛的研究.
- IPF会导致逐渐的肺功能丧失和呼吸衰竭.
研究的目的:
- 审查目前对IPF的理解,包括其流行病学和风险因素.
- 探索IPF诊断和治疗方面的进展.
- 突出正在进行的研究和IPF潜在的未来疗法.
主要方法:
- 使用PubMed和谷歌学者进行了全面的文献审查.
- 对流行病学数据和环境风险因素的分析.
- 检查当前的诊断方法和治疗策略.
主要成果:
- 两种已批准的口服药物,pirfenidone和 nintedanib,减缓了IPF的进展.
- 皮尔芬尼具有抗纤维素,抗氧化和抗炎作用.
- 丁丁达尼布抑制了与纤维化有关的关键生长因子受体.
结论:
- 皮尔芬尼和宁泰达尼布提供了较慢的疾病进程,并具有良好的安全性.
- 对遗传学,生物标志物和表观遗传学的进一步研究对IPF至关重要.
- 目前正在进行的临床试验旨在发现治疗异常性肺纤维化.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Introduction to Fibroblasts
Types of Intermediate Filaments
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
